| Bayer (Schweiz) AG - Rivaroxaban vascular Bayer 2.5mg, Filmtabletten | | 69234 | | 01 | | Rivaroxaban vascular Bayer 2.5mg | | Filmtabletten | | B01AF01 | | Rivaroxaban | | 06.04.2023 | | |
| | Composition | | rivaroxabanum 2.5 mg, cellulosum microcristallinum, carmellosum natricum conexum, hypromellosum, lactosum monohydricum 36 mg, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, macrogolum 3350, E 171, E 172 (flavum), pro compresso obducto corresp. natrium 0.6 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Rivaroxabanum | 2.5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 36 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Pro Compresso Obducto | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 56 | PR | PR | B | | No | | 003 | 196 | PR | PR | B | | No |
|
|
